INTRODUCTION
Helicobacter pylori is a gram-negative bacterium that colonizes the human gastric and duodenal mucosa of more than half of the world's population. The bacteria are found associated with the mucous layer as well as attached to the gastric epithelium 1, 2 . H.
pylori infection is often acquired during childhood and is spread through person-toperson contact or by ingesting contaminated food and water. The bacteria persist in the gastric environment for decades and even throughout the life span of the host 3 . H.
pylori infection is the strongest known risk factor for gastroduodenal ulcers, and is the first bacterium defined as a causative agent of gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue lymphoma 4 .
H. pylori possesses a number of different colonization and virulence determinants.
The urease enzyme, encoded by ureA and ureB, neutralizes gastric acidity by degrading urea at the site of colonisation 5 , and the bacterial flagella mediate motility 6 .
The VacA cytotoxin 7, 8 and CagA pathogenicity island contribute to cytotoxicity and affect epithelial cell viability 9, 10 . The best-studied H. pylori adhesins are outer membrane proteins that bind carbohydrate structures on host cell glycoproteins. The
BabA adhesin binds fucosylated blood group antigen Lewis-b 11 and the sialic acidbinding adhesin SabA, binds to sialylated carbohydrate structures on gastric epithelial cells 12 . Several other outer membrane proteins, such as HopZ, HopH, AlpA and AlpB, have also been shown to mediate bacterial attachment to host cells 13, 14 .
The complement system of the host has a crucial role in eliminating pathogenic organisms. Many bacteria have developed the ability to escape the machinery of the human complement system by interfering with complement regulatory factors. CD46, a human cell surface glycoprotein expressed by virtually all cells except erythrocytes, regulates complement activation by serving as a cofactor in the proteolysis of deposited C3b and C4b by serine protease factor I. CD46 consists of four homologous complement control protein repeats (CCPR-1, -2, -3, and -4), a serine-threonineproline (STP)-rich domain, a transmembrane hydrophobic domain, a cytoplasmic anchor and a cytoplasmic tail. Four major isoforms of CD46 are expressed due to alternative splicing and the choice between one of two cytoplasmic tails, Cyt-1 and Cyt-2 [15] [16] [17] . CD46 interacts with adenovirus 18 , human herpes virus 6 19 , pathogenic Neisseria [20] [21] [22] , measles virus 23 and Streptococcus pyogenes. 24 Infection of epithelial cells by N. gonorrhoeae and S. pyogenes triggers shedding of CD46 25, 26 . Although CD46 is expressed in human gastric epithelium 27 , the role of CD46 in H. pylori infection has not yet been elucidated.
In this study, we show that H. pylori triggers shedding of CD46 from host cells. Also,
we provide evidence that a soluble form of CD46 binds to H. pylori and inhibits growth in a dose and time dependent manner. The bactericidal activity was retained in a 24 amino acid synthetic peptide derived from CD46, which also inhibited the urease activity. Finally, we demonstrate that oral administration of the CD46-peptide eliminates H. pylori infection in a mouse model of disease. Taken together, this study demonstrates a novel function of CD46 as a virulence blocker that interferes with the capacity of the pathogen to survive in the acidic gastric mucosa.
RESULTS

H. pylori induces shedding of CD46 from human gastric epithelial cells
To determine if infection by H. pylori resulted in modulation of CD46 expression, we used AGS gastric epithelial cells, which express high levels of CD46
( Supplementary Fig. 1a) , and three H. pylori wild-type strains, J99, HPAG1 and 26695. At 18 h post infection, all three strains adhered to AGS cells (Fig. 1a) .
Analysis by flow cytometry revealed that H. pylori infection dramatically reduced the CD46 amount at the cell surface (Fig. 1b) . To assess whether the loss of CD46 was due to internalization or shedding of the protein, the supernatants of infected and uninfected AGS cells were analyzed in ELISA. The amount of CD46 was more than 6-fold increased in supernatants of infected AGS cells compared to uninfected cells (Fig. 1c) Indeed, staining with propidium iodine and analysis by flow cytometry revealed that 60% of cells were positive at 18 h post infection ( Supplementary Fig. 1b ),
suggesting that shedding of CD46 is linked to apoptosis.
H. pylori binds to recombinant CD46 (CD46)
Since CD46 is released from gastric epithelial cells after H. pylori infection, we hypothesized that H. pylori might bind CD46. To investigate whether CD46 interacts with H. pylori, we measured binding of purified CD46 to bacteria. Recombinant CD46, composed of the extracellular domain of the protein (Fig. 2a) , was generated as a thioredoxin-CD46 fusion protein (Supplementary Fig. 2a ). Binding of CD46 to H. pylori was first assessed by a microtiter plate assay in which bacterial lysates were overlaid with CD46 followed by anti-CD46 antibodies. All three tested H. pylori strains tested bound CD46, however, strain J99 and HPGA1 bound better than strain 26695 (Fig. 2b) . We next analyzed binding of CD46 to bacteria by flow cytometry and confirmed that all three H. pylori strains bind to CD46 even though the bindinglevel varies slightly between the strains. As negative control we used nonpathogenic E. coli, which failed to bind CD46, indicating specificity for H. pylori (Fig. 2c) . In addition, we could not detect interaction between CD46 and Pseudomonas aeruginosa or Campylobacter jejuni (Supplementary Fig. 2b ).To further study the interaction between CD46 and H. pylori, we designed a competition assay using the CD46-binding ligand C3b. Strain J99 was selected for these studies since it demonstrated slightly better binding to CD46 compared to the other strains (according to Fig. 2c ).
Recombinant CD46 was pre-incubated with C3b or anti-CD46 antibodies for 1 h, and then added to bacteria. Flow cytometry analysis showed that both C3b and CD46
antibodies blocked binding of CD46 to H. pylori (Fig. 2d) . These data suggest that
C3b and H. pylori recognize overlapping or closely linked CD46-domains. We next wanted to directly visualize the interaction between CD46 and bacteria by microscopic examination. Analysis by immunofluorescence microscopy confirmed binding of CD46 to H. pylori (Fig. 2e) , but revealed an unexpected alteration of bacterial morphology, including loss of the bacterial spiral shape, increased bacterial aggregation and bacterial lysis upon incubation with CD46 (Fig. 2f) . The control Trx protein did not promote morphological changes of the bacteria. Taken together, these data demonstrate that H. pylori recognizes CD46 in a species-specific manner and indicate that CD46 is bactericidal against H. pylori.
CD46 inhibits growth of H. pylori
The bactericidal effect of CD46 was further evaluated by incubating H. pylori J99 with different concentrations of CD46 for 6 h. Addition of CD46 impaired bacterial survival in a dose dependent manner, whereas the control protein thioredoxin (Trx) had no bactericidal effect (Fig. 3a) . We next investigated bacterial survival over time by incubating a fixed concentration of H. pylori with CD46 for 0 h, 6 h, and 24 h.
Clearly, bacterial survival decreased by longer incubation time (Fig. 3b) 
CD46 interacts with UreA and AhpC
In order to find bacterial proteins that bind to CD46, we passed whole bacterial extracts of strain J99 through Talon affinity columns pre-conjugated with recombinant CD46. The eluted fraction was separated by SDS-PAGE and stained with Coomassie brilliant blue (Fig. 3d) . This revealed two apparent bands of 26 kD and 21 kD, which were identified as UreA and AhpC (alkyl hydroperoxide reductase)
by mass spectrometry, respectively. The urease of H. pylori is composed of UreA and UreB and is an important virulence factor required for bacterial survival in the acidic gastric environment 32 . AhpC acts as a peroxide reductase in reducing organic hydroperoxides and as a molecular chaperone for prevention of protein misfolding under oxidative stress 33, 34 . To further confirm that UreA and AhpC are ligands of CD46, we generated a ΔureA mutant and a double ΔureA/ΔahpC mutant of strain J99.
The strains were allowed to bind CD46 and then analyzed by flow cytometry.
Deletion of both ureA and ahpC completely abolished binding of CD46 to bacteria, whereas deletion of ureA partially decreased CD46-binding, suggesting that both
UreA and AhpC participate in the interaction with CD46 (Fig. 3e) . To evaluate if binding of CD46 to UreA inhibits urease activity, total protein extracts of H. pylori J99 were first incubated with CD46 for 1 h, and then analyzed for urease activity.
This resulted in more than 96% reduction of urease activity compared to the control (Fig. 3f) . These data suggest that CD46 inhibits the urease activity by directly targeting UreA.
Identification of CD46 peptides with bactericidal effects towards H. pylori
To identify CD46 domain(s) with inhibiting activity against H. pylori, four peptides corresponding to hydrophilic, potentially exposed CCPR regions of CD46 were synthesized (Fig. 4a) . Bacteria were incubated with each peptide for 6 h and the bactericidal effect was evaluated. Peptide P1 and P2 had no detectable effect on bacterial survival, while both peptide P3 and P4 inhibited bacterial growth (Fig. 4b) .
The P3-peptide was the most efficient inhibitor by killing 80% of the bacteria. This made us focus further studies towards this peptide. Incubation of bacteria with peptide P3 for 6 h demonstrated a dose dependent bactericidal effect with 40% killing at 5 µM peptide and 80% at 30 µM peptide (Fig. 4c) . These data suggest that the strongest interaction with H. pylori occurs within CCPR-3 region of CD46, which is also the previously reported binding region to C3b.
To verify that also the P3-peptide interacts with UreA and AhpC, FITC-labeled peptides were incubated with wild-type, ΔureA, and ΔureA/ΔahpC and analyzed by flow cytometry. The P3-peptide bound to H. pylori in a similar pattern as CD46, i .e.
ΔureA bound to 47% as compared to wild-type and ΔureA/ΔahpC did not bind. The control peptide P1 and a random peptide (RP) did not bind to bacteria (Fig. 4d) . We next analyzed urease activity in H. pylori J99 lysates after incubation with peptide P3
and peptide P1 (control). The P3-peptide, but not the P1 peptide, inhibited urease activity of J99 (Fig. 4e) 
5e-g).
These predictions and modelling data support that binding of CD46, and especially peptide P3, occurs at sites that are likely to affect either active sites of the urease or the functional region of AhpC.
Oral administration of P3-peptide eliminate H. pylori in a mouse model system
Since urease activity is essential for bacterial survival at the acidic gastric mucosa, we next evaluated whether the P3-peptide could affect H. pylori in vivo colonization of mice. We used H. pylori strain 67:21 for the in vivo experiments, since this strain colonizes the gastric mucosa of mice, in contrast to J99. Strain 67:21 exhibited similar binding and interaction with CD46 and the P3-peptide as compared to J99
( Supplementary Fig. 3 ). The interaction between H. pylori and CD46 was not altered by changes in pH (Supplementary Fig 2c) . To mimic a more human-like stomach, we used transgenic mice expressing CD46 in a human-like manner 35 . CD46 transgenic mice were infected orally with H. pylori once per day for 3 days. At 8 weeks post infection, colonization of H. pylori was detected by immunohistochemistry at the gastric mucosa. The mice were then orally fed with 20
µg P3-peptide suspended in water once per day for 2 weeks, whereas the control mice were fed with water in the same way. At the end of the peptide treatment, stomach tissue were collected, homogenized and plated for viable counts. Mice fed with water (-P3) showed high bacterial loads of 10 5 CFU/g, whereas bacteria were not detected in P3-treated mice (+P3), supporting that the P3-peptide had eradicated H. pylori from the mouse stomach (Fig. 6a) . Further, tissue sections from stomach of P3-treated, untreated and uninfected (control) mice were examined for bacterial signals by fluorescence microscopy using H. pylori specific antibodies. H. pylori was detected at the gastric surface mucosa in non-treated mice; however, P3-treated and control mice showed no detectable H. pylori (Fig. 6c) .
It has been reported that CD46 protein level at the gastric mucosa is decreased in humans infected with H. pylori 36 . We therefore stained the tissue sections with CD46
antibodies and revealed significantly reduced CD46 levels in infected mice, but normal CD46 amounts in peptide-P3 treated mice (P≤ 0.05) ( Fig. 6b and c) . The most likely explanation is that loss of CD46 occurs as a result of bacterial infection 28 .
Cytokines are key molecules in induction of inflammatory responses and consequent cell damage. Therefore, we investigated the host response elicited by H. pylori and measured IL-10, IL-6, and TNF-α, in the gastric mucosa. The level of IL-10 in P3-treated mice was higher than in water-treated mice, whereas IL-6 and TNF-α levels remained unaffected. The finding of increased level of the anti-inflammatory cytokine IL-10 of treated mice, suggests that P3 supplementation may reduce inflammatory responses ( Fig. 5d) . Taken together, our data demonstrate that peptide P3 has an in vivo bactericidal effect and indicate that supplementation of P3 might enhance antiinflammatory responses in the host. It has been reported that a glycoprotein of CD43 containing ∝1,4-GlcNAc-capped Oglycan inhibit bacterial growth since it disrupts the biosynthesis of peptidoglycan in the cell wall of H. pylori 37 . Interaction between CD46 and bacteria has not previously been reported to reduce bacterial survival. We found that binding of CD46 led to reduced growth, membrane permeabilization, morphological abnormalities and death, suggesting that CD46 targets an essential molecule of the bacteria. By using affinity columns, UreA was pulled down from bacterial lysates. Urease is consistently present in all naturally occurring strains and mutants lacking UreA fail to colonize mice 10 .
DISCUSSION
Indeed, the current study clearly implicates CD46 as inhibitor of urease activity, and earlier findings by Nagata et al. (1993) 38 suggested that inhibition of urease activity is lethal to H. pylori. In addition to UreA, the affinity columns and mass spectrometry also identified AhpC. To combat the reactive oxygen species released by the host, H.
pylori is equipped with a number of detoxifying proteins. The most abundant among these is AhpC, a thioredoxin-dependent member of the 2-Cys peroxi-redoxins 33 
Adherence assay
Bacteria (MOI=100) were allowed to adhere to AGS cells for 18 h, unbound bacteria were washed away and adhered bacteria were plated for viable counts. See
Supplementary Methods for a detailed protocol.
Flow cytometry analysis of cells
CD46 expression on AGS cells: AGS cells were infected with H. pylori (MOI=100)
for 18 h. Cells were collected, washed, and stained with polyclonal antibody to CD46
and Alexa488-conjugated anti-IgG antibody before analysis by flow cytometry (for detailed protocol see Supplementary Methods).
ELISA analysis
Cell supernatants: AGS cells cultured in 6 well plates were infected with H. pylori (MOI=100) for 18 h. Supernatants were collected, concentrated, re-suspended in 100 mM bicarbonate buffer (pH 9.5), and used to coat microtiter plates. CD46 was detected with polyclonal antibody against CD46 for 1 h followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG as indicated in (Supplementary Methods).
Interaction between CD46 and H. pylori: Microtiter plates were coated with 10 7 CFU/ml of bacteria. One hundred µl of 2.5 µg/ml CD46 were added for 1 h. CD46
was detected with antibodies as above.
Purification of CD46 and affinity chromatography
Recombinant CD46 was expressed in E. coli and purified (see Supplementary Methods). Cell extracts of H. pylori J99 (10 8 bacteria/ml) was prepared as described previously 38 , and loaded onto an Talon metal affinity column (Clontech) conjugated with recombinant CD46. Fractions were eluted, separated on SDS-PAGE, stained
with Coomassie brilliant blue, and identified by mass spectroscopy. Competition: Purified CD46 of 30 µg/ml was pre-incubated for 1 h with 2.5 µg/ml of C3b (Calbiochem, CA, USA), or with 2 µg/ml of antibody to CD46 (H-294, Santa Cruz), or buffer alone. H. pylori was added at 10 7 CFU/ml for additional 2 h, whereafter the samples were fixed, stained with anti-CD46 antibody and analyzed by flow cytometry. To evaluate bacterial lysis, CD46 (30 µg/ml) was pre-incubated with 2.5 µg/ml of C3b for 1 h, and followed by additional 2 h incubation with H. pylori. Fluorescence microscopy.
30 µg/ml CD46 was incubated for 2 h with 10 6 CFU/ml H. pylori and stained according to the procedure for flow cytometry. Images were collected at 63x magnification using a fluorescent microscope (Zeiss). Images were further processed with Adobe Photoshop. For histological evaluation, the stomach tissues were fixed and embedded in paraffin. Intensity of signals was analyzed by Image J.
Survival assay.
Two hundred µl of 10 5 CFU/ml H. pylori suspension was incubated with 30 µg/ml CD46 for 0, 6 or 24 h or with 0-100 µg/ml CD46 for 6 h. Thioredoxin and PBS were used as control. Bacteria were serially diluted and plated on Columbia Blood Agar plates and incubated for 4-7 days before enumeration. H. pylori was incubated with 30 µM peptide P1, P2, P3 or P4, or incubated with different concentrations of the P3-peptide, and the growth of bacteria was monitored as above.
Construction of mutants, urease activity assay, and molecular docking.
See Supplementary Methods for protocols.
In vivo experiments.
A CD46 receptor transgenic mouse strain (hCD46Ge) that expresses the CD46 receptor in a pattern closely mirroring that in humans was used 22, 41 . ELISA of cell culture supernatants. AGS cells were infected as above. Supernatants (10 ml) of infected and uninfected cells were collected after 18 h, concentrated, and re-suspended in 100 mM bicarbonate buffer (pH 9.5). Microtiter plates were incubated over night at 4°C with 100 µl bacterial suspension per well. Wells were blocked with 5% skim milk for 2 h, washed with PBS, and incubated with polyclonal antibody against CD46 for 1 h (H-294, Santa Cruz, 200 µg/ml, diluted 1:5000).
Incubation with primary antibody was followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (Invitrogen, 1:4000). After washing with PBS, substrate was added and absorbance at 450 nm was measured. Experiments were repeated twice in triplicate and the mean and standard deviation were calculated.
Purification of CD46.
The complete extracellular region of the CD46-BC1 isoform was PCR amplified with Fig. 2a) .
ELISA of the interaction between CD46 and H. pylori. Bacteria from plates were suspended into Brucella broth containing 8% horse serum and 5ml/liter isovitox and harvested by centrifugation, washed three times with PBS, and re-suspended to 10 7 CFU/ml in 100 mM bicarbonate buffer, pH 9.5. Microtiter plates were incubated over night at 4°C with 100 µl bacterial suspension per well. Wells were blocked with 5% skim milk for 2 h, washed with PBS, and incubated with 100 µl of 2.5 µg/ml recombinant CD46 for 1 h, and with polyclonal antibody against CD46 for 1 h (H-294, Santa Cruz, 200 µg/ml, diluted 1:5000). Incubation with secondary antibody and substrate was done as above. Experiments were repeated twice in triplicate and the mean and standard deviation were calculated.
Generation of H. pylori ΔureA mutant
Chloramphenicol resistant gene (CAT) was PCR amplified from pACY184 using primers Cat1 (5ʹ′-CACTACGCTGGAAAATCAGTAAGTTGGCAGCATCACCCG-
3ʹ′) and Cat2 (5ʹ′-TTTAGCACCATGCCAGGCGTTTAAGGGCACCAATAAʹ′). H. pylori J99 genomic DNA was isolated from bacteria grown for 48 h by using Qiagen
Genomic DNA kit as per manufacture's instructions. Two pairs of ureA-specific primers U1 (5ʹ′-TTGGCGCTGGGGTTTCTAATGT-3ʹ′), U2 (5ʹ′-ACTTATACTGATTTTCCAGCGTAGTGGAGCATCAACTT-3ʹ′) and U3 (5ʹ′-CTTAAACGCCTGGCATGGTGCTAAAAGCATGACAAC-3ʹ′), U4 (5ʹ′-CGCTTGCAAAAGCTGTAGGGAT-3ʹ′), were used to PCR amplify the up-and downstream regions, respectively. PCR products were purified using Qiagen Gel purification kit. The primers were designed with overlapping homologies at the ends.
The three PCR products were combined into one fragment by five cycles without any primers followed by 30 cycles with two primers. The construct was introduced into H.
pylori J99 by spot transformation. Bacteria grown for 48 h were suspended into 0.2 ml Brucella broth (Becton Dickinson) and spotted as 100 µl (1x10 8 bacteria/ml) onto Columbia blood agar plates. After incubation with 150 ng of purified DNA product, the bacterial transformation spot was spread over the plate and incubated for further 24 h. The bacteria were then moved onto selective Columbia blood agar plates containing 15 µg of chloramphenicol/ml and incubated for 3 to 7 days. Positive clones were confirmed by PCR, western blot and urease activity test. ΔureA deficient H. pylori as above by selective plate (10 µg/ml kanamycin and 10 µg/ml chloramphenicol). Positive transformants were confirmed by PCR using the primers ahpC-fwd (5'-CCACAAAGGTTACCACAAGATCAGG-3') and ahpC-rev
Generation of H. pylori
Flow cytometry analysis of bacteria. H. pylori at 10 7 CFU/ml were pre-incubated with 30 µg/ml recombinant CD46 or 30 µM FITC-P3 peptide for 2 h at 37°C. Urease activity assay. The method to measure urease activity has previously been described 38 . Briefly, bacteria at 10 8 CFU/ml were centrifuged, washed and resuspended with ice-cold de-gassed 20 mM sodium phosphate (pH 6.8). The suspension was sonicated for 3 min in 30 s pulses with ice cooling, centrifuged at 10 000 g for 20 min to remove cell debris. The supernatant was used for the urease activity assay. One µg of protein was incubated with 30 µg/ml of purified CD46 or peptides for 2 h at 37°C. After incubation, 100 µl of 50 mM phosphate buffer pH 6.8 containing 50 mM urea, 0.02% phenol red was added to each well. The color change was measured at 560 nm with micro-plate reader. Urease activity was assayed by adding urea-containing reaction buffer as indicated in methods.
Figure 4
Mapping the H. pylori-binding region of CD46. µg/ml CD46 for 2 h in Brucella broth with pH 2, 4, or 7, washed, and stained as above. 
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